Distinct Role of TP53 Co-mutations in Different EGFR Subtypes Mediating the Response to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Lihong Wei, Yi Lao, Tongze Fu, Zhongpeng Xie, Yanxia Wang, Tiantian Yang, Leilei Huang, Jiahua Liu, Man Shu, Tian,Shuhua Li, Qiong He, Jianwen Zhou,Xuchao Zhang, Huipin Wang, Juan Du, Xinwei Wang,Zheng Yang,Lihong Bai,Zunfu Ke

Clinical lung cancer（2025）

Cited 0|Views2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined